Mohammad Alzoubi: One Month of Dual Antithrombotic Therapy After PCI Was Non-Inferior to 12 Months
Mohammad Alzoubi, Senior Neurologist at MOH, shared a post on LinkedIn about a recent article by Yohei Sotomi et al., published in adding:
“The OPTIMA-AF RCT (n=1,079) showed that 1-month dual antithrombotic therapy after PCI in AFib was non-inferior to 12 months for death or TE events and reduced major or clinically relevant nonmajor bleeding.”
Title: 1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial
Authors: Yohei Sotomi, Ken Kozuma, Yoshiharu Higuchi, Gaku Nakazawa, Yoshihiro Morino, Kenji Ando, Junya Ako, Kengo Tanabe, Takashi Muramatsu, Ken Kobayashi, Yasuhiro Ichibori, Takayuki Ishihara, Keiji Hirooka, Satoru Suwa, Takayuki Warisawa, Toru Naganuma, Atsushi Kikuchi, Ryu Shutta, Naotaka Okamoto, Yasuhiro Tanabe, Atsunori Okamura, Kosuke Kashiwabara, Shungo Hikoso, Yasushi Sakata
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:57Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award